Where is the live CopyMark page for USPTO serial 79245543?

The live record is at https://getcopymark.com/trademark/79245543. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns DERMOPLASMINE?

According to the public USPTO record for serial number 79245543, the listed owner(s) include: BOIRON, BOIRON, BOIRON.

What is USPTO serial number 79245543?

Serial number 79245543 is the USPTO application identifier for the mark DERMOPLASMINE. It is used to track examination, publication, and registration of this trademark.

What is the current status of DERMOPLASMINE?

DERMOPLASMINE (79245543) currently shows USPTO status code 709 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover DERMOPLASMINE?

The public record lists International Classes: 003, 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: DERMOPLASMINE Serial# 79245543 | status 709; last event C71T | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DERMOPLASMINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JANET G RICCIUTI

JANET G RICCIUTI JANET GILBERT RICCIUTI PC1830 S STREET NWWASHINGTON, DC 20009UNITED STATES

Goods and services

Class	Description	Status	First use
003	Cosmetic products, namely, non-medicated cosmetic cream for treatment of skin irritations	SECTION 71 - CANCELLED	—
005	Pharmaceutical preparations, namely, homeopathic and phytotherapeutic specialties for the treatment of irritation to the skin and nasal mucosa	SECTION 71 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Apr 3, 2026	C71T	CANCELLED SECTION 71	—
Sep 17, 2024	REM3	COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED	—
Oct 14, 2023	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
Dec 5, 2020	INNA	INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE	—
Nov 30, 2020	INPR	PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED	—
Apr 1, 2020	CORR	CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED	—
Mar 31, 2020	REIN	REINSTATED	—
Mar 31, 2020	APRE	CASE ASSIGNED TO POST REGISTRATION PARALEGAL	—
Mar 20, 2020	CRCV	CORRECTION TRANSACTION RECEIVED FROM IB	—
Jan 9, 2020	FINA	FINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE	—
Jan 3, 2020	DENC	NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED	—
Jan 3, 2020	DETH	DEATH OF INTERNATIONAL REGISTRATION	—
Dec 17, 2019	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Sep 17, 2019	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 4, 2019	RNWL	INTERNATIONAL REGISTRATION RENEWED	—
Jul 2, 2019	NPUB	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	—
Jul 2, 2019	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 28, 2019	GPNX	NOTIFICATION PROCESSED BY IB	—
Jun 12, 2019	OPNS	NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB	—
Jun 12, 2019	OP2R	NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB	—
Jun 12, 2019	NONP	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	—
May 28, 2019	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
May 25, 2019	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
May 25, 2019	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
May 25, 2019	ALIE	ASSIGNED TO LIE	—
May 21, 2019	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 25, 2019	RFNT	REFUSAL PROCESSED BY IB	—
Jan 5, 2019	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Jan 5, 2019	RFRR	REFUSAL PROCESSED BY MPU	—
Dec 20, 2018	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Dec 19, 2018	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2018	DOCK	ASSIGNED TO EXAMINER	—
Dec 1, 2018	MAFR	APPLICATION FILING RECEIPT MAILED	—
Nov 27, 2018	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Nov 26, 2018	LIMI	LIMITATION FROM ORIGINAL APPLICATION ENTERED	—
Nov 15, 2018	SDRC	SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB	—

DERMOPLASMINE